Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study

Abstract

Low bone mineral density (BMD) was recently identified as a novel risk factor for patients with hepatocellular carcinoma (HCC). In this multicenter study, we aimed to validate the role of BMD as a prognostic factor for patients with HCC undergoing transarterial chemoembolization (TACE).

Publication
European Radiology
Moon Kim
Moon Kim
Team Lead Annotation Lab
Jens Kleesiek
Jens Kleesiek
Professor of Translational Image-guided Oncology